Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.52 USD | +0.23% | +0.19% | +123.93% |
05-31 | Fusion Pharmaceuticals Gets Court Order Approving AstraZeneca Deal | MT |
05-29 | Fusion Pharmaceuticals Shareholders Approve AstraZeneca Deal | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
- Stock Market
- Equities
- FUSN Stock
- News FUSN PHAR
- Wedbush Lifts Fusion Pharmaceuticals' Price Target to $13 From $12 After Acquisition News, Keeps Outperform Rating